Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human liver cancer cells Hep3B: Valeric acid treated vs. Control

ABSTRACT: Human liver cancer cells Hep3B: Valeric acid treated vs. Control

PROVIDER: PRJNA589081 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Human liver cancer cells Hep3B: Valeric acid treated vs. Control

Project description:Transcriptional profiling of human liver cancer cells (Hep3B) treated with valeric acid compared to control.

2021-11-12 | GSE140280 | GEO

Transcriptional profile comparing Hep3B transfected with miR-19b inhibitor with Hep3B transfected with control

Project description:miR-19b was up-regulated with hepatocellular carcinoma. We compared the transcriptional profile of Hep 3B transfected with miR-19b inhibitor with Hep3B transfected with control to identify genes affected by miR-19b knockdown. Hep 3B_miR-19b transfected vs Hep 3B_control transfected

2015-07-22 | E-GEOD-69519 | biostudies-arrayexpress

Human liver tissues: cancer vs. control

Project description:Human liver tissues: cancer vs. control

| PRJNA701644 | ENA

Expression data from liver cancer cell line Hep3B

Project description:Expression data from liver cancer cell line Hep3B

| PRJNA428723 | ENA

Rat liver. Control vs. Chemical treated: time course

Project description:This SuperSeries is composed of the following subset Series: GSE16340: Rat liver. Control vs. Chemical treated, 3 days GSE16394: Rat liver. Control vs. Chemical treated, 28 days GSE16743: Rat liver: Control vs. Chemical treated, 14 days Refer to individual Series

2009-06-23 | E-GEOD-16752 | biostudies-arrayexpress

RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells

Project description:RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells

| PRJNA496576 | ENA

The Impact of HYOU1 Knockdown on Gene Expression in Hep3B Liver Cancer Cells

Project description:In order to explore the role of HYOU1 in liver cancer cells and identify its downstream target genes, we utilized lentiviral technology to knock down HYOU1 expression and established a stable HYOU1 knockdown Hep3B liver cancer cell line. Gene expression profiling was then performed using two groups of cells: the control group and the stable knockdown group (n=3).

2025-03-31 | GSE291417 | GEO

Differential gene expression in Hep3B and Hep3B SOX4-/- cells

Project description:Overexpression of SOX4 in various kinds of cancers specimen was associated with poor prognosis of patients; however, the role of SOX4 in angiogenesis or tumor microenvironment modulation remains unclear. Therefore the endogenous SOX4 was knockout and the differential gene expression between Hep3B and Hep3B SOX4-/- cells were examined via genechip. We found that the differentially expressed genes, EzH2, a SOX4-associated partner, and CXCL12, were repressed in Hep3B SOX4-/- cells compared with parental Hep3B; these results were further assessed via qRT-PCR in Hep3B SOX4-/- versus Hep3B cells.

2020-12-01 | GSE141909 | GEO

Hep3B time-course

Project description:A time-course (T0, 15, 30 min, 1, 3, 6 or 16 hours) of mRNA abundance changes was studied in the human Hep3B hepatoma cell line challenged with a pro-inflammatory cytokine-enriched medium (CM,conditionned medium) vs control medium (NCM,non conditionned medium). Paired cultures prepared from a same batch of trypsinized cells were challenged with CM vs NCM for a given length of time and this was repeated in three independent experiments (S1,S2,S3). Keywords: time-course

2004-12-10 | GSE2046 | GEO

Liver in humanized-liver mice: Control vs ortho-toluidine treatment

Project description:Liver in humanized-liver mice: Control vs ortho-toluidine treatment

| PRJNA858765 | ENA